Monoclonal antibodies for prophylactic and therapeutic use against viral infections

Both, Leonard, Banyard, Ashley C, van Dolleweerd, Craig, Wright, Edward, Ma, Julian K C and Fooks, Anthony R (2013) Monoclonal antibodies for prophylactic and therapeutic use against viral infections. Vaccine, 31 (12). pp. 1553-1559. ISSN 0264410X

[img] PDF - Published Version
Available under License Creative Commons Attribution-NonCommercial No Derivatives.

Download (487kB)


Neutralizing antibodies play an essential part in antiviral immunity and are instrumental in preventing or modulating viral diseases. Polyclonal antibody preparations are increasingly being replaced by highly potent monoclonal antibodies (mAbs). Cocktails of mAbs and bispecific constructs can be used to simultaneously target multiple viral epitopes and to overcome issues of neutralization escape. Advances in antibody engineering have led to a large array of novel mAb formats, while deeper insight into the biology of several viruses and increasing knowledge of their neutralizing epitopes has extended the list of potential targets. In addition, progress in developing inexpensive production platforms will make antiviral mAbs more widely available and affordable.

Item Type: Article
Schools and Departments: School of Life Sciences > Biochemistry
Subjects: Q Science > QR Microbiology > QR0355 Virology
Depositing User: Edward Wright
Date Deposited: 14 Aug 2018 12:18
Last Modified: 14 Aug 2018 12:18

View download statistics for this item

📧 Request an update